In non-small cell lung cancer, STAT2 was a prognostic biomarker and high mRNA expression of STAT2 was significantly associated with shorter overall survival.[8] Moreover, high transcription levels of STAT2 was associated with better relapse-free survival in breast cancer.[27]. This evidence concerns the gene STAT2 and breast carcinoma.